All > Mindfulness > Insomnia

Experimental group for Insomnia

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
InsomniaMindfulness - Behavioral
Eligibility
20 - 50
All Sexes
What conditions do you have?
Select

Study Summary

This is a pilot study evaluating the feasibility and acceptability of a non-pharmacological, mind-body intervention to improve sleep quality, including a preliminary evaluation of neurophysiological signals. The study involves 4 weeks of guided mind-body practice at home using a smartphone app during bedtime and pre/post in-lab sleep study visits.

Eligible Conditions
  • Insomnia

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
ALRN-6924 Dose plus TAC
1
MOv19-BBz CAR T cells
1
Codrituzumab

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: At one month follow up visit

At baseline and at the end of 4-week program
Insomnia Severity Index
Polysomnogram-derived sleep efficiency
Polysomnogram-derived sleep onset latency
Week 4
Acceptability
At one month follow up visit
Feasibility (i.e., subject retention at initial follow-up assessment)

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
ALRN-6924 Dose plus TAC
1
MOv19-BBz CAR T cells
1
Codrituzumab

Trial Design

2 Treatment Groups

Control group
1 of 2
Experimental group
1 of 2

Active Control

Experimental Treatment

12 Total Participants · 2 Treatment Groups

Primary Treatment: Experimental group · No Placebo Group · N/A

Experimental group
Behavioral
Experimental Group · 1 Intervention: Mindfulness · Intervention Types: Behavioral
Control groupNoIntervention Group · 1 Intervention: Control group · Intervention Types:
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mindfulness
2014
Completed Phase 3
~2910

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: at one month follow up visit

Who is running the clinical trial?

Beth Israel Deaconess Medical CenterLead Sponsor
778 Previous Clinical Trials
844,421 Total Patients Enrolled
4 Trials studying Insomnia
262 Patients Enrolled for Insomnia

Eligibility Criteria

Age 20 - 50 · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top